Phar­ma­co­ge­net­ics: FDA re­leas­es ta­ble of gene-drug in­ter­ac­tions

The FDA on Thurs­day pub­lished a ta­ble iden­ti­fy­ing more than 50 gene-drug in­ter­ac­tions that the agency says are sup­port­ed by sci­en­tif­ic ev­i­dence and an­nounced it is con­sid­er­ing new ap­proach­es to eval­u­at­ing phar­ma­co­ge­net­ic as­so­ci­a­tions.

“Con­sis­tent with our mis­sion to pro­tect and pro­mote pub­lic health, we be­lieve it is im­por­tant to take steps now to help en­sure that claims be­ing made for phar­ma­co­ge­net­ic tests of­fered to­day are ground­ed in sound sci­ence to avoid in­ap­pro­pri­ate man­age­ment of pa­tients’ med­ica­tions,” said Cen­ter for De­vices and Ra­di­o­log­i­cal Health Di­rec­tor Jeff Shuren and Cen­ter for Drug Eval­u­a­tion and Re­search Di­rec­tor Janet Wood­cock.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER